Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 367

Two great examples of why company management matters

The COVID-19 crisis has delivered an historic challenge to health authorities and macroeconomic policymakers alike. For many company management teams, it has above all tested their recent decisions on how they allocate capital.

Adjectives used to describe the past 12 months are losing their meaning; unprecedented, tragic, volatile, worrisome and so on. Throw in some comments about the extraordinary levels of monetary and fiscal stimulus and there you have 99% of the commentary that will review this amazing period.

We do not know what the future looks like, but we are optimistic. Worst-case health and economic scenarios, forecast by some, have not eventuated in Australia. Let’s hope that continues.

Rather than making vague prognostications on what the future holds or predicting how stock markets will react, we share some insights from our investment experience and outline how this shapes our process and portfolios.

Management and capital allocation

It has been said that we can only judge the quality of management decisions made during the good times after the cycle turns and the ‘tide goes out’. Whether it be the need to:

  • write down acquisitions purchased at the top of the cycle
  • repair balance sheets with dilutive equity raisings and dividend cuts
  • jettison assets that are now ‘non core’

... the recent market dislocations have shone the spotlight on management decisions made over the past cycle.

Ultimately, we look to invest the money of our clients in companies run by executives who we trust and view as highly competent. Management teams influence the creation of shareholder value through their decisions on capital allocation.

Here are two examples that illustrate the shareholder wealth that management teams can create when they allocate capital with skill and insight.

Example 1: the battle of the plumbing wholesalers

It’s not only products and business models that create wealth. Management teams make decisions on how to deploy capital and over time those decisions compound on each other leading to potentially vastly different outcomes.

Take the example of two businesses that, on the surface, operate what would seem to be similar business models (wholesale distribution) selling similar products (plumbing supplies) to similar trade customers. If we rewind back to 1998, Reece and Tradelink were generating similar earnings of roughly $20 million a year.

Now let’s fast forward 20 years, a timeframe in which management decisions have compounded their effects on the outcomes for the businesses.

Figure 1: Reece and Tradelink operating earnings 1998 and 2019

Source: Airlie Funds Management

The difference is stark. Reece has produced an 18-fold largely-organic increase in earnings while Tradelink earnings have actually fallen over the last two decades.

What was the difference over those 20 years? We attribute it overwhelmingly to Reece management. The business has been run by members of the Wilson family for decades. They skilfully invested capital in high-returning projects to grow the business and stayed focused on core competencies with the long term in mind. We also believe the family’s significant shareholding (about 75%) of the business over that period further contributed to great decisions on capital. They had ‘skin in the game’.

This owner-managed structure is one we like. We have several such long-term holdings across our portfolios including Reece, Premier Investments, Mineral Resources and Nick Scali.

Example 2: Wesfarmers

If there was ever a good corporate structure in which to examine decisions on capital allocation it would have to be the conglomerate. While there has been much debate on the case for and against the conglomerate, proponents of the structure point to the ability of the corporate centre to make value-accretive capital decisions so that the whole is greater than the sum of the parts. Of course, if we invert this, the risk with the conglomerate is the company trades at a persistent discount to the sum of its parts.

We believed this was the case with Wesfarmers in mid-2016. As the share price chart in Figure 2 shows, Wesfarmers traded sideways for the best part of five years from 2013 to 2018 when return on equity was stuck around 10% (adjusting for write-downs). Few material changes had been made to the asset portfolio and the company was dealing with some poor capital-allocation decisions in relation to the expansion of Bunnings into the UK.

Our analysis indicated there was value trapped inside the collection of assets that could be unlocked and we engaged with management on these views. Around mid-2017, Rob Scott was appointed CEO of Wesfarmers and quickly made significant changes.

Rob and his team skilfully extracted Wesfarmers from the UK, demerged Coles and made other material divestments that amounted to almost $20 billion across 10 transactions. The company’s share price has rallied since this time.

Figure 2: Wesfarmers share price since 2013 ($A adj. for Coles demerger)

Source: Airlie Funds Management


Register here to receive the Firstlinks weekly newsletter for free

It doesn’t matter until it matters … and it has really mattered this year!

Not only did Wesfarmers management adeptly capitalise on the final stages of the bull market to sell assets at good prices, it built resiliency and optionality into the balance sheet heading into the downturn. This contrasts with how the Wesfarmers balance sheet was positioned during the GFC and should bode well for the company’s ability to make value-accretive transactions at attractive prices.

This focus on the balance sheet and a company’s financial strength is another central component of the Airlie investment process. It helps us identify opportunities such as Wesfarmers, and avoid 'value traps' whereby valuations may seem appealing but with the wrong level of debt for the business model, a company is unable to consistently generate adequate cash flow and returns for shareholders.

Corporate debt levels haven’t seemed to matter to the market over the last few years and some management teams have been lured by cheap debt to fund buy-backs or increase dividend payouts. The economic impacts of COVID-19 have quickly changed the market's view on the importance of financial strength.

Figure 3 shows the outperformance of those stocks in the ASX200 Industrials index with low financial leverage in March and April 2020. 

Figure 3: Outperformance of stocks with low financial leverage in March and April 2020
ASX 200 Industrials Total Return by Net Debt to EBITDA

Source: MST Marquee, Airlie Funds Management

The strength of 'low equitisers'

We have seen over $20 billion of equity capital raised on the ASX in the past four months to repair balance sheets. However, we believe that it is not only in the short term that financial strength matters. Over the long term, companies that are able to fund their operations, including growth, from internally generated cash flows tend to outperform those that repeatedly need to come to the market to raise equity.

This collection of companies that repeatedly require new equity capital, or 'equitisers', have underperformed by 9% p.a. relative to low equitisers on the ASX over the past 20 years. These decisions about how to fund the business tie back to management decisions on capital allocation.

Figure 4: Long-term outperformance of companies with low levels of 'equitisation'

Source: MST Marquee, Airlie Funds Management

 

Looking to the future

We are ultimately optimistic, even though we are unable to predict the future. The government and community response in Australia has kept us in relatively good shape. We are mindful that in the very short term, government policy responses will be key to both the health and economic outlook. Currently in Australia, the Job Keeper/Job Seeker fiscal programmes are due to be removed later this year (update - they have now been modified and extended into 2021). From our discussions with company executives, there is caution on the ramifications for employment and consumer spending from the removal of these programmes.

While the near-term outlook is uncertain, we have confidence in our investment process. It is robust and has been tested through multiple cycles over two decades. We continue to expect those companies with high-quality management teams and strong balance sheets to do well over the medium to long term.

 

Matt Williams is a Portfolio manager for Magellan-owned, Airlie Funds Management. Magellan Asset Management is a sponsor of Firstlinks. This article has been prepared for general information purposes only and must not be construed as investment advice or as an investment recommendation. This material does not consider your investment objectives, financial situation or particular needs.

For more articles and papers from Magellan, please click here.

 

RELATED ARTICLES

The business case for diversity and inclusion

Companies crying wolf

banner

Most viewed in recent weeks

After 30 years of investing, I prefer to skip this party

Eventually, prices become so extreme they bear no relationship to reality, and a bubble forms. I believe we are there today, not for all stocks but for many in the technology space.

Australian house prices: Part 2, the bigger picture

There is good reason to believe the negatives will continue to outweigh the positives over the next 12 to 18 months. There is more concern about house prices than the short-term indicators suggest.

How to handle the riskiest company results in history

It is better to miss a results bounce and buy after the company has delivered than it is to step on a landmine. With such uncertainty, avoid FOMO by following these result season investing tips.

Australian house prices: Part 1, how worried should we be?

Three key indicators are useful for predicting the short-term outlook for house prices, although tighter lockdowns make the outlook gloomier. There is enough doubt to create cause for concern.

Welcome to Firstlinks Edition 367

There is a similarity between the current health crisis and economic crises of the past. For COVID-19, record amounts of biotech funding from government agencies and private companies are looking for a vaccine. Likewise, central banks once struggled treating recessions but the 'vaccine' now is record amounts of financial stimulus to ensure liquidity. While the world awaits a COVID treatment, markets are purring along, at least until side effects hit.

  • 22 July 2020

Welcome to Firstlinks Edition 369

Imagine you had perfect foresight about COVID-19 at the start of the year. You correctly foresaw that the global pandemic would kill over 700,000 among 20 million infections by August. In Australia, borders would close, cities would be locked down, most mortgagors would be on income support and companies would be allowed to trade while insolvent. You then had to guess how much the stock market would fall. Would you say about 10%?

  • 6 August 2020

Latest Updates

Shares

How to handle the riskiest company results in history

It is better to miss a results bounce and buy after the company has delivered than it is to step on a landmine. With such uncertainty, avoid FOMO by following these result season investing tips.

Shares

The rise of Afterpay and emergence of a new business model

Sometimes the simplest ideas are the best. The founders of Afterpay stumbled on the attraction for consumers of paying by instalments, and now retailers must offer the facility or lose business.

Property

WFH and its impact on Australian offices and tenants

Although most office workers are currently WFH, an energy and a buzz comes from working in the same physical space. Other benefits include team building, relationships, talent mentoring and creative collaboration.

Fixed interest

Why 2020 has been the year of the bond market

Going back to June 2019, investors would have questioned the logic of diversifying away from outperforming growth assets. But when markets feel at their best, it is paramount to keep a perspective on long-term goals.

Investment strategies

Is 5G all hype or real investable opportunity?

While its impact will take time to unfold, 5G will meaningfully change the world. Once adoption takes hold, there is huge potential for its application across a wide range of industries.

Property

Australian house prices: Part 1, how worried should we be?

Three key indicators are useful for predicting the short-term outlook for house prices, although tighter lockdowns make the outlook gloomier. There is enough doubt to create cause for concern.

Property

Australian house prices: Part 2, the bigger picture

There is good reason to believe the negatives will continue to outweigh the positives over the next 12 to 18 months. There is more concern about house prices than the short-term indicators suggest.

Sponsors

Alliances

© 2020 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use.
Any general advice or class service prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, has been prepared by without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.